Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$924K Sell
12,857
-428
-3% -$40.3K 0.16% 94
2026
Q1
$1.57M Sell
13,285
-115
-0.9% -$14.2K 0.3% 67
2025
Q4
$1.69M Sell
13,400
-6
-0% -$783 0.32% 61
2025
Q3
$1.96M Sell
13,406
-154
-1% -$23.3K 0.39% 56
2025
Q2
$2.11M Buy
13,560
+13
+0.1% +$2.06K 0.52% 49
2025
Q1
$2.23M Sell
13,547
-174
-1% -$28.9K 0.54% 55
2024
Q4
$2.24M Sell
13,721
-181
-1% -$32.4K 0.52% 52
2024
Q3
$2.72M Sell
13,902
-46
-0.3% -$8.48K 0.62% 54
2024
Q2
$2.42M Sell
13,948
-23
-0.2% -$3.83K 0.6% 54
2024
Q1
$2.36M Buy
13,971
+22
+0.2% +$4.12K 0.59% 54
2023
Q4
$2.75M Sell
13,949
-141
-1% -$25K 0.72% 49
2023
Q3
$2.45M Sell
14,090
-670
-5% -$122K 0.71% 51
2023
Q2
$2.54M Sell
14,760
-57
-0.4% -$9.86K 0.7% 50
2023
Q1
$2.47M Buy
14,817
+704
+5% +$115K 0.73% 48
2022
Q4
$2.07M Buy
+14,113
New +$2.09M 0.64% 49

Other funds holding ZTS

Legacy Trust's ZTS Position: Q2 2026 in Review

Legacy Trust reduced its Zoetis (ZTS) stake by 3.2% in Q2 2026, selling an estimated $40.3K and leaving 12,857 shares worth $924K. The position accounts for 0.16% of the portfolio, ranked #94.

Legacy Trust first reported a position in ZTS in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.75M in Q4 2023. 1,433 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Legacy Trust held 12,857 shares of Zoetis worth $924K as of Q2 2026.
  • Legacy Trust sold 428 Zoetis shares in Q2 2026, an estimated $40.3K.
  • Zoetis made up 0.16% of Legacy Trust's portfolio in Q2 2026, its #94 holding.
  • Legacy Trust first reported a position in Zoetis in Q4 2022 and has held it in 15 quarters since.
  • Legacy Trust's Zoetis position peaked at $2.75M in Q4 2023.
  • 1,433 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Legacy Trust's 13F filing for Q2 2026, filed 31 Jul 2026.